SavedAdd your journal

Journals / Glokom Katarakt / 2017 / Cilt: 12 - Sayı: 2

Çocuk Hastada Aripiprazol'ün İndüklediği Akut Miyopi: Olgu Sunumu

Aripiprazole Induced Acute Myopia In a Child: A Case Report

ÖZALP EKİNCİ
ERDEM DİNÇ
ÖZER DURSUN
Nuran EKİNCİ
SERKAN GÜNEŞ
Pages
145–147
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We present a child with major depression who developed acute myopia with aripiprazole use.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aripiprazole, is frequently used in child and adolescent psychiatry clinical practice.
📊
Key Findings & Data:Ocular side effects of aripiprazole have been reported to be very rare.
💡
Conclusion & Impact:We present a child with major depression who developed acute myopia with aripiprazole use.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aripiprazole, is frequently used in child and adolescent psychiatry clinical practice. Ocular side effects of aripiprazole have been reported to be very rare. We present a child with major depression who developed acute myopia with aripiprazole use.

Özet

Aripiprazol çocuk ve adölesan psikiyatri klinik pratiğinde sık kullanılmaktadır. Aripiprazolün oküler yan etkilerinin oldukça nadir görüldüğü rapor edilmiştir. Bu yazıda majör depresyon nedeniyle aripiprazol kullanan ve akut miyopi gelişen bir olgu sunulmuştur.

🔖

Cite This Article

EKİNCİ, Ö., DİNÇ, E., DURSUN, Ö., EKİNCİ, N., GÜNEŞ, S. (2017). Çocuk Hastada Aripiprazol'ün İndüklediği Akut Miyopi: Olgu Sunumu. Glokom Katarakt, Cilt: 12 - Sayı: 2, 145–147. https://ajindex.com/articles/177737

References (11)

  1. Greenaway M, Elbe D. Focus on aripiprazole: a review of its use in child and adolescent psychiatry. J Can Acad Child Adolesc Psy- chiatry 2009;18:250-60.
  2. Gupta S, Masand P. Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders. Ann Clin Psychiatry 2004;16:155-66. Basgul SS. Aripiprazole use in Children and Adolescents: A Pub- lic Hospital Child Psychiatry Outpatient Department's Experience. Bulletin of Clinical Psychopharmacology 2014;24:31-8.
  3. Nair AG, Nair AG, George RJ, Biswas J, Gandhi RA. Aripiprazole induced transient myopia: a case report and review of literature. Cutan Ocul Toxicol 2012;31:74-6.
  4. Berman RM, Marcus RN, Swanink R, McQuade RD, Carson WH, Corey-Lisle PK, et al. The effi cacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study. J Clin Psyc- hiatry 2007;68:843-53.
  5. Kaya H, Yılbas B, Dilbaz N, Yazar Z. Aripiprazole induced acute myopia: a case report. Bull Clin Psychopharmacol 2009;19(Suppl 1):147-8.
  6. Selvi Y, Atli A, Aydin A, Yener HI. Aripiprazole-related acute tran- sient myopia and diplopia: a case report. J Clin Psychopharmacol 2011;31:249-50.
  7. Karadağ H, Acar M, Özdel K. Aripiprazole Induced Acute Tran- sient Bilateral Myopia: A Case Report. Balkan Med J 2015;32:230- 2. Costagliola C, Parmeggiani F, Sebastiani A. SSRIs and intraocu- lar pressure modifi cations: evidence, therapeutic implications and possible mechanisms. CNS Drugs 2004;18:475-84.
  8. Patel OP, Simon MR. Oculogyric dystonic reaction to escitalop- ram with features of anaphylaxis including response to epinephri- ne. Int Arch Allergy Immunol 2006;140:27-9.
  9. Schmitt JA, Riedel WJ, Vuurman EF, Kruizinga M, Ramaekers JG. Modulation of the critical fl icker fusion effects of serotonin reuptake inhibitors by concomitant pupillary changes. Psychop- harmacology (Berl) 2002;160:381-6.
  10. Molden E, Lunde H, Lunder N, Refsum H. Pharmacokinetic vari- ability of aripiprazole and the active metabolite dehydroaripipra- zole in psychiatric patients. Ther Drug Monit 2006;28:744-9.
  11. Boulton DW, Balch AH, Royzman K, Patel CG, Berman RM, Mal- likaarjun S, et al. The pharmacokinetics of standard antidepres- sants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder. J Psychop- harmacol 2010;24:537-46.